FINCH THERAPEUTICS GROUP, INC. Operating Lease Cost
FINCH THERAPEUTICS GROUP, INC. reported Operating Lease Cost of $1.20 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-08-13
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for the quarter ending 2024-06-30 was $1.20M, a 28.37% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for the quarter ending 2024-03-31 was $1.20M, a 30.24% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for the quarter ending 2023-12-31 was $744.00K, a 59.91% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for the quarter ending 2023-09-30 was $1.38M, a 19.84% decline year-over-year.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for fiscal 2023 was $5.53M, a 5.68% increase from fiscal 2022.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for fiscal 2022 was $5.23M, a 291.47% increase from fiscal 2021.
- FINCH THERAPEUTICS GROUP, INC. operating lease, cost for fiscal 2021 was $1.34M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-13 | $2.40M 10-Q · filed 2024-08-13 | $3.15M derived: sum of 3 quarters · filed 2024-08-13 | $4.53M derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-10 | $1.95M derived: sum of 2 quarters · filed 2024-05-10 | $3.33M derived: sum of 3 quarters · filed 2024-05-10 | $5.01M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.13M derived: sum of 2 quarters · filed 2024-03-25 | $3.80M derived: sum of 3 quarters · filed 2024-08-13 | $5.53M 10-K · filed 2024-03-25 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-08 | $3.06M derived: sum of 2 quarters · filed 2024-08-13 | $4.78M 10-Q · filed 2023-11-08 | $6.64M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $1.68M 10-Q · filed 2024-08-13 | $3.40M 10-Q · filed 2024-08-13 | $5.26M derived: sum of 3 quarters · filed 2024-08-13 | $6.98M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.72M 10-Q · filed 2024-05-10 | $3.58M derived: sum of 2 quarters · filed 2024-05-10 | $5.30M derived: sum of 3 quarters · filed 2024-05-10 | $6.61M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $3.58M derived: sum of 2 quarters · filed 2024-03-25 | $4.89M derived: sum of 3 quarters · filed 2024-03-25 | $5.23M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.72M 10-Q · filed 2023-11-08 | $3.04M derived: sum of 2 quarters · filed 2023-11-08 | $3.37M 10-Q · filed 2023-11-08 | $3.59M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $1.31M 10-Q/A · filed 2023-08-11 | $1.65M 10-Q/A · filed 2023-08-11 | $1.86M derived: sum of 3 quarters · filed 2023-08-11 | $2.30M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $339.00K 10-Q · filed 2023-05-10 | $553.00K derived: sum of 2 quarters · filed 2023-05-10 | $988.00K derived: sum of 3 quarters · filed 2023-05-10 | $1.36M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $649.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.02M derived: sum of 3 quarters · filed 2023-03-23 | $1.34M 10-K · filed 2023-03-23 |
| 2021-09-30 | $435.00K 10-Q · filed 2022-11-10 | $805.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.12M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $370.00K 10-Q · filed 2022-08-11 | $687.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $317.00K 10-Q · filed 2022-05-16 |